Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;31(8):e16320.
doi: 10.1111/ene.16320. Epub 2024 Apr 30.

Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy

Affiliations

Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy

Negin Badihian et al. Eur J Neurol. 2024 Aug.

Abstract

Background and purpose: Primary lateral sclerosis (PLS) is a neurodegenerative disorder that primarily affects the central motor system. In rare cases, clinical features of PLS may overlap with those of progressive supranuclear palsy (PSP). We investigate neuroimaging features that can help distinguish PLS with overlapping features of PSP (PLS-PSP) from PSP.

Methods: Six patients with PLS-PSP were enrolled between 2019 and 2023. We compared their clinical and neuroimaging characteristics with 18 PSP-Richardson syndrome (PSP-RS) patients and 20 healthy controls. Magnetic resonance imaging, 18F-flortaucipir positron emission tomography (PET), quantitative susceptibility mapping, and diffusion tensor imaging tractography (DTI) were performed to evaluate eight brain regions of interest. Area under the receiver operating characteristic curve (AUROC) was calculated.

Results: Five of the six PLS-PSP patients (83.3%) were male. Median age at symptom onset was 61.5 (52.5-63) years, and all had mixed features of PLS and PSP. Volumes of the pallidum, caudate, midbrain, and cerebellar dentate were smaller in PSP-RS than PLS-PSP, providing good discrimination (AUROC = 0.75 for all). The susceptibilities in pallidum, midbrain, and cerebellar dentate were greater in PSP-RS compared to PLS-PSP, providing excellent discrimination (AUROC ≥ 0.90 for all). On DTI, fractional anisotropy (FA) in the posterior limb of the internal capsule from the corticospinal tract was lower in PLS-PSP compared to PSP-RS (AUROC = 0.86), but FA in the superior cerebellar peduncle was lower in PSP-RS (AUROC = 0.95). Pallidum flortaucipir PET uptake was greater in PSP-RS compared to PLS-PSP (AUROC = 0.74).

Conclusions: Regional brain volume, tractography, and magnetic susceptibility, but not tau-PET, are useful in distinguishing PLS-PSP from PSP.

Keywords: neurodegenerative disorders; primary lateral sclerosis; progressive supranuclear palsy; quantitative susceptibility mapping; tractography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Partial tractography reconstructions from diffusion tensor imaging techniques. The corticospinal tracts (CSTs) in yellow were partially reconstructed and centered in a region representing the right (red) and left (blue) posterior limb of the internal capsule (PLIC). The superior cerebellar peduncle (SCP) was also reconstructed (green). The lateral ventricular system (LV) is represented as a topographical reference (purple). CST_l, left CST; CST_r, right CST; R, right.
FIGURE 2
FIGURE 2
Fluorodeoxyglucose positron emission tomography scan of patients with primary lateral sclerosis with overlapping features of progressive supranuclear palsy. L, left; R, right; Sup, superior.
FIGURE 3
FIGURE 3
Quantitative susceptibility mapping images of representative progressive supranuclear palsy (PSP)–Richardson syndrome (PSP‐RS) and primary lateral sclerosis (PLS)‐PSP patients. The PSP‐RS patient has greater susceptibility signals than the PLS‐PSP patient in the pallidum, substantia nigra, red nucleus, and cerebellar dentate.

Similar articles

Cited by

References

    1. Turner MR, Barohn RJ, Corcia P, et al. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020;91(4):373‐377. doi: 10.1136/jnnp-2019-322,541 - DOI - PMC - PubMed
    1. Coon EA, Whitwell JL, Jack CR Jr, Josephs KA. Primary lateral sclerosis as progressive supranuclear palsy: diagnosis by diffusion tensor imaging. Mov Disord. 2012;27(7):903‐906. doi: 10.1002/mds.24990 - DOI - PMC - PubMed
    1. Vacchiano V, Bonan L, Liguori R, Rizzo G. Primary lateral sclerosis: an overview. J Clin Med. 2024;13(2):578. doi: 10.3390/jcm13020578 - DOI - PMC - PubMed
    1. Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32(6):853‐864. doi: 10.1002/mds.26987 - DOI - PMC - PubMed
    1. Iwata NK, Kwan JY, Danielian LE, et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain. 2011;134(Pt 9):2642‐2655. doi: 10.1093/brain/awr178 - DOI - PMC - PubMed